Medscape Hematology-Oncology Headlines Medscape Hematology-Oncology Headlines RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Magnetic Seeds/Guidewires for Breast Cancer Localization? Magnetic Seeds/Guidewires for Breast Cancer Localization?
Paramagnetic seeds work as well as guidewires for breast tumor localization and are easier to use, but it ' s not yet clear whether the costs of the seeds outweigh the benefits.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 5, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

' Left in the Dark': Prior Auth Erodes Trust, Costs More'Left in the Dark': Prior Auth Erodes Trust, Costs More
A surprising prior authorization requirement left an oncologist ' s patient in extreme pain over the weekend.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 4, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

New Research Points to a Better Biomarker for MSI mCRC New Research Points to a Better Biomarker for MSI mCRC
David J. Kerr, CBE, MD, DSc, discusses the potential for identifying patients who are likely to be more responsive to immune checkpoint inhibitors.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 2, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

How Do Patients View Their Cancer Test Results? How Do Patients View Their Cancer Test Results?
With electronic patient portals, patients see their test results sooner and more frequently before their clinician, a recent analysis found.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 28, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

No Added Benefit From Chemo in This Breast Cancer Subtype No Added Benefit From Chemo in This Breast Cancer Subtype
Adding chemotherapy to endocrine therapy for women with ER-positive, HER2-negative invasive lobular carcinoma does not improve survival outcomes.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 28, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Phase 1 Trials: Are We Using Optimal Drug Dose Schedules? Phase 1 Trials: Are We Using Optimal Drug Dose Schedules?
David J. Kerr, CBE, MD, DSc, discusses considerations for dosing schedules in Phase 1 trials.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 28, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

New Trials in Breast Cancer: Could Your Patient Benefit? New Trials in Breast Cancer: Could Your Patient Benefit?
Patients with breast cancer might be eligible to enroll in one of these clinical trials.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 27, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Is It Possible to Predict the Risk for Pancreatic Cancer? Is It Possible to Predict the Risk for Pancreatic Cancer?
A US-based team seeks to develop and validate a model allowing clinicians to predict the risk for pancreatic cancer.MDedge (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 21, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

AI in Oncology: Sorting Through Misinformation AI in Oncology: Sorting Through Misinformation
David J. Kerr, CBE, MD, DSc, discusses the use of artificial intelligence in oncology now and in the future.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 21, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

The Latest Findings on Major Breast Cancer Trials The Latest Findings on Major Breast Cancer Trials
Here ' s a roundup of the most recent data from five phase 3 trials presented at SABCS 2023.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 21, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Serum Hormones May Predict AI Benefit for BC Prevention Serum Hormones May Predict AI Benefit for BC Prevention
Measuring serum hormone concentrations in postmenopausal women at high risk for developing BC may help identify those most likely to benefit from preventive treatment with an aromatase inhibitor.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 21, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

ESD Curbs Adenoma Recurrence but More Adverse Events ESD Curbs Adenoma Recurrence but More Adverse Events
For large colonic adenomas, endoscopic submucosal dissection reduces the recurrence rate compared with endoscopic mucosal resection, but the adverse event rate is higher.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 20, 2023 Category: Cancer & Oncology Tags: Gastroenterology Source Type: news

New Multiple Myeloma Staging Systems Outperform the Standard New Multiple Myeloma Staging Systems Outperform the Standard
Findings from a large US cohort study show comparable accuracy, but better discrimination of patients across disease stages.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 20, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

GLP-1 RAs Associated With Reduced CRC Risk in T2DM GLP-1 RAs Associated With Reduced CRC Risk in T2DM
The effects were more profound in patients with overweight and obesity in addition to diabetes.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 19, 2023 Category: Cancer & Oncology Tags: Gastroenterology Source Type: news

FDA OKs Enfortumab Vedotin Plus Pembro for Urothelial Cancer FDA OKs Enfortumab Vedotin Plus Pembro for Urothelial Cancer
The combination is the first approved alternative to first-line chemotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 18, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news